Ventyx Biosciences, Inc. (VTYX)
8.695
+0.18
(+2.17%)
USD |
NASDAQ |
Dec 10, 16:00
8.695
0.00 (0.00%)
After-Hours: 16:38
Ventyx Biosciences Shareholders Equity (Quarterly): 191.36M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 713.03M |
| Genprex, Inc. | 0.7678M |
| Moderna, Inc. | 9.33B |
| Neumora Therapeutics, Inc. | 132.16M |
| BioAge Labs, Inc. | 277.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 211.46M |
| Total Liabilities (Quarterly) | 20.10M |
| Debt to Equity Ratio | 0.0524 |
| Current Ratio | 17.86 |
| Net Debt Paydown Yield | 0.11% |